ScoreWhy is FibroGen, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -13.16% and Operating profit at 13.74% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -93.57
2
The company declared negative results in Mar'25 after positive results in Dec'24
- NET SALES(Q) Lowest at USD 1.35 MM
- PRE-TAX PROFIT(Q) At USD -13.38 MM has Fallen at -31.2%
- NET PROFIT(Q) At USD -13.29 MM has Fallen at -38.15%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -12.21%, its profits have risen by 83.6%
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.58% over the previous quarter and currently hold 0.69% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
5
Below par performance in long term as well as near term
- Along with generating -12.21% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is FibroGen, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
FibroGen, Inc.
-19.55%
0.31
2124.68%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-13.16%
EBIT Growth (5y)
13.74%
EBIT to Interest (avg)
-93.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
-6.83
Tax Ratio
0.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
61.61%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.15
EV to EBIT
-2.96
EV to EBITDA
-3.19
EV to Capital Employed
-0.56
EV to Sales
0.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -23.5 MM
NET PROFIT(HY)
Higher at USD -29.93 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -31.28 %
RAW MATERIAL COST(Y)
Fallen by -1,035.42% (YoY
-21What is not working for the Company
NET SALES(Q)
Lowest at USD 1.35 MM
PRE-TAX PROFIT(Q)
At USD -13.38 MM has Fallen at -31.2%
NET PROFIT(Q)
At USD -13.29 MM has Fallen at -38.15%
CASH AND EQV(HY)
Lowest at USD 56.98 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.05 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.06 times
OPERATING PROFIT MARGIN(Q)
Lowest at -848.52 %
Here's what is working for FibroGen, Inc.
Operating Cash Flow
Highest at USD -23.5 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at -31.28 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -1,035.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for FibroGen, Inc.
Net Sales
At USD 1.35 MM has Fallen at -94.76%
over average net sales of the previous four periods of USD 25.71 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Net Sales
Lowest at USD 1.35 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -13.38 MM has Fallen at -31.2%
over average net sales of the previous four periods of USD -10.2 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -13.29 MM has Fallen at -38.15%
over average net sales of the previous four periods of USD -9.62 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit Margin
Lowest at -848.52 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Cash and Eqv
Lowest at USD 56.98 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 0.05 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 3.06 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
